Circulating Tumor-Tissue-Modified Viral DNA Testing

This evidence review addresses the use of circulating tumor-tissue-viral modified (TTMV) human papillomavirus (HPV) DNA testing for cancer management. The purpose of tumor-informed TTMV-HPV DNA testing in individuals with HPV-related cancer is to predict disease outcomes to inform treatment decisions and to monitor for recurrence following treatment.